Clindamycin in the oral treatment of putative anaerobic pneumonias.
D000284:Administration, Oral; D000328:Adult; D000332:Aerobiosis; D000368:Aged; D000380:Agranulocytosis / Q000139:chemically induced; D000693:Anaerobiosis; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D001439:Bacteroides / Q000302:isolation & purification; D001442:Bacteroides Infections / Q000188:drug therapy / Q000382:microbiology; D002981:Clindamycin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008168:Lung / Q000000981:diagnostic imaging; D008169:Lung Abscess / Q000188:drug therapy* / Q000382:microbiology; D008297:Male; D008875:Middle Aged; D011014:Pneumonia / Q000188:drug therapy* / Q000382:microbiology; D011859:Radiography; D013183:Sputum / Q000382:microbiology; D013290:Streptococcal Infections / Q000188:drug therapy / Q000382:microbiology; D013291:Streptococcus / Q000302:isolation & purification; D013492:Suppuration
D002981:Clindamycin